Diazyme acquires Alfa Wassermann Diagnostic Technologies
What's the deal? Diazyme LaboratoriesDealroom has a profile for this one. Try Dealroom → has acquired Alfa Wassermann Diagnostic TechnologiesDealroom has a profile for this one. Try Dealroom → for an undisclosed sum. Peter Napoli, chief executive officer of Alfa Wassermann Diagnostic Technologies, will continue to run the business as part of Diazyme's management team.
What's the endgame? Diazyme gains Alfa Wassermann's nationwide customer-support network and installed base of instruments. The company said the deal will help it reach physicians, veterinarians, researchers, and laboratories with diagnostic testing solutions.
Why it matters: Chong Yuan, managing director of Diazyme Laboratories, said the acquisition strengthens the company's ability to serve customers through a "strong nationwide customer support network, wide instrumentation placement, and a demonstrated commitment to service excellence."
Napoli said joining Diazyme is "synergistic" for Alfa Wassermann and will help provide better services and a wider test menu to customers.
The signal: The deal adds to steady consolidation among diagnostics firms seeking broader test menus and deeper distribution. For Diazyme, buying an established service network is a faster route to scale than building one.
Read more: financialpost.com
Image credit: IAEA Imagebank
